1 / 25

Sponsorship of Research Avoiding chaos & confusion

Sponsorship of Research Avoiding chaos & confusion. Bob Lobley Research & Development Manager Royal Liverpool & Broadgreen University Hospitals NHS Trust Chris Counsell Research & Development Manager University Hospital Birmingham NHS Foundation Trust. Background.

Download Presentation

Sponsorship of Research Avoiding chaos & confusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Sponsorship of ResearchAvoiding chaos & confusion Bob LobleyResearch & Development ManagerRoyal Liverpool & Broadgreen UniversityHospitals NHS Trust Chris CounsellResearch & Development ManagerUniversity Hospital Birmingham NHS Foundation Trust

  2. Background • Research Governance Framework (DoH 2001) • EU Clinical Trials Directive (2001/20/EC) • Medicines for Human Use (Clinical Trials) Regulations 2004 • RGF 2nd edition (April 2005) But there is • widespread confusion about what is involved • conflict about who is responsible • wide variation in practice

  3. Roles & responsibilities

  4. Basic Principles What … • All research in Health & Social Care must have a sponsor • Overall responsibility for initiation, management & conduct of study • Legal liability for conduct of Clinical Trial of IMP • Must be identified at outset (required by MHRA, REC, many funders) • Candidates are employer, NHS organisation or funder • Significant problem area – uncertainty, misunder-standing, inadequate communication and resources

  5. Who can Sponsor? • Legal entity (organisation or individual) • Sole sponsor – single organisation accepts all responsibilities • Joint sponsors – several organisations accept all responsibilities (joint & several liability) • ‘Co-sponsors’ – several organisations divide responsibilities between them (not recognised elsewhere in EU)

  6. Legal responsibilities – CTIMP • Regulatory permissions • authorisations & ethical review • Research conduct • GCP, provision of IMPs • Pharmacovigilance • adverse event reporting, SUSARs N.B. Sponsor may delegate duties but retains overall responsibility AND due diligence is a defence

  7. Responsibilities – RGF • Respect for dignity, rights, safety and well-being of participants • Independent peer review to assure scientific quality and value for money of research • Appropriate ethics committee or independent ethics reviewer has given a favourable opinion • Expertise and experience of researchers and access to the necessary resources • Ensuring collection of high quality data, appropriate data analysis and necessary data protection

  8. Responsibilities – RGF • Study arrangements are consistent with the Research Governance Framework • Organisations and individuals involved in the research agree (and document) the division of responsibilities between them • Written agreements between parties regarding management and monitoring of the study • All clinical trials are registered

  9. Responsibilities – RGF • Appropriate compensation arrangements are in place for negligent (and non-negligent) harm • Arrangements for alerting the sponsor and other stakeholders of significant developments regarding the safety of individuals or scientific direction • Arrangements for concluding the study and disseminating the findings N.B. These should be recorded in study-specific agreements!

  10. Problem Areas • Finding a Sponsor – NHS trust or HE institution? • Sole or group sponsorship? • Student (educational/vocational) research • International studies ??? • Assigning and documenting responsibilities e.g. authorisation, monitoring, pharmacovigilance • Delays to commencement of research …

  11. Potential Solutions • Framework Agreements: high level, between established partners • Specific memorandum • Sponsorship agreements: study- and site-specific! But: • Agreements important 1st step but not sufficient • Implementation & communication are key: • common/joint processes & procedures • sharing information from outset (no surprises)

  12. Sponsorship Memorandum Initially: • Univ: Trust should sponsor all clinical research involving patients, specimens or information • Trust: Univ should sponsor all academically- led research BUT many projects fall into both categories!

  13. Sponsorship Memorandum (2) For all joint research: • Trust & Univ will together determine who will act as sponsor on case-by-case basis • Trust & Univ will each register as a sponsor with DoH • Prior written agreement by both parties required when study is to be co-sponsored by Trust & Univ • MoU on Sponsorship to replace corresponding section of Framework Agreement with Univ

  14. Sponsorship Memorandum (3) Where … • All investigators are employed by Trust- Trust will normally be sole sponsor • One or more investigators is University employee holding Honorary Trust Contract - Trust will normally co-sponsor with Univ • None of investigators is Trust employee and no Trust patients or staff are subjects in research - Trust will normally not be a sponsor

  15. Co-sponsorship Arrangements Division of responsibilities: Part 3: authorisations & ethical review (Univ) Part 4: GCP and conduct of research (Trust) Part 5: Pharmacovigilance (Trust) (www.rlbuht.nhs.uk/research)

  16. Sponsorship document suite • Drafted by R&D Forum working group, led by Brenda Zinober & Bob Lobley • Designed to provide advice, guidance & model agreements for sponsorship of non-commercial R&D • Comprising: • Principles • Questions & Answers • Model sponsorship agreement (legal) • Model sponsorship agreement (non-legal)

  17. Sponsorship Agreements Considerations: • Several different types of Agreement already in use • Inconsistency between documents is potential source of delay • Better to adapt existing agreements than reinvent wheels Legal vs. non-legal: • Legal agreements strongly disfavoured by DH & research community but already being used • DH/UKCRC to persuade universities to avoid use of legal agreements for non-commercial R&D • Aim to produce small set of model Agreements (legal and non-legal)

  18. Model Agreement (Legal) Purpose: • to provide a standard, legal contract between Sponsor(s) and individual sites, especially for Clinical Trials of IMPs • for studies where one or more of parties is notan NHS organisation • suited to studies involving financial or other transactions between parties • suitable for single or multiple site studies

  19. Model Agreement (Legal) Content (12 pp): • sets out roles & responsibilities of Sponsor(s) and site organisation • specifies obligations of parties, including confidentiality, publication rights, intellectual property rights, duration & termination arrangements, etc. • specifies activities that site must perform • specifies financial arrangements, provision of drugs, etc. (where appropriate) • other contractual essentials

  20. Model Agreement (Legal) Schedules: • protocol & funding agreement (if applicable) • responsibilities of parties, including governance requirements & legal responsibilities under CT Regulations • services to be provided by site • programme of work to be performed • financial arrangements (where applicable)

  21. Model Agreement (non-legal) Purpose: • to provide a standard, bilateral agreement setting out sponsorship arrangements between NHS sponsor & study site • for studies where legal contract inappropriate e.g. between NHS organisations • for studies that are not clinical trials under the Clinical Trials Regulations 2004 • suitable for single or multiple site studies

  22. Model Agreement (non-legal) Content (6 pp): • sets out roles & responsibilities of Sponsor(s) and site organisation in brief • covers obligations of confidentiality, monitoring requirements, liabilities, intellectual property rights, publication rights, duration of study, termination arrangements, etc. in brief

  23. Model Agreement (non-legal) Appendices – templates for: • the allocation of responsibilities between parties • the responsibilities of investigators • monitoring arrangements • model site file

  24. Sponsorship scenarios • Single centre study with Framework Agreement or Memorandum between NHS & academic partners • letter confirming acceptance of standard arrangements for sponsorship • Clinical trials of IMP with legal & contractual obligations • Sponsorship agreement (legal?) • All other studies • Sponsorship agreement (non-legal)

  25. Conclusions • Sponsorship isa challenge • Progress dependent on • close liaison/formal agreements between research partner(s) • appropriate resources & expertise • common/joint processes & procedures • Good guidance, e.g. from MRC & NHS R&D Forum • R&D Office alwaysgets the blame!

More Related